PF-04958242

· Biogen

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PF-04958242, covering 2015-12-17 to 2017-10-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS) [Phase 2]

See pricing